Make the world "smile"as a science solution provider.

Since our founding in 2012, we MiRTeL have provided "Telomere test" to visualize "Mibyo" (pre-disease) and "MiR test" to stratify disease risk at an early stage as a service to "visualize" invisible health and illness.

For further development, we combine the research results, technologies, and know-how that we have accumulated so far with the research results of various universities and companies. Then As a venture company, each one of us aims MiRTeL to be the only one company of "Liquid Biopsy" x "Data Science" that develops and provides a new "visualization" service that solves the problems faced by health and illness based on the three powers of "foresight," "creativity" and "mobility" and the four unwavering values of "quality," "honesty," "challenge" and "trust."

As a science solution provider that "visualizes" health and illness from various perspectives so that all people in the world can lead healthy and prosperous lives, we will be close to them as the foundation of life and society. I want to make people involved in MiRTeL 's services "smile" by making anxieties of health and illness and hopes that people around the world have visible in science.

That is our wish as MiRTeL.

Toshiya Kato

Representative Director CEO & President, MiRTeL Co., Ltd.